Cardiac Remodeling in Chronic Kidney Disease

Area of Science:

• Nephrology
• Cardiology
• Pathophysiology

Background:

• Chronic kidney disease (CKD) is linked to significant cardiac remodeling, impacting patient quality of life and survival.
• Existing treatments for CKD-related cardiac dysfunction are insufficient.
• The decline in kidney function disrupts metabolic pathways, affecting the heart via organ crosstalk.

Purpose of the Study:

• To review established and potential pathophysiological mechanisms of cardiorenal crosstalk in CKD.
• To identify how uremia-induced senescence and disease progression affect cardiac function.
• To explore potential therapeutic targets and relevant animal models for understanding and treating these conditions.

Main Methods:

• Literature review of established and potential pathophysiological cardiorenal crosstalk mechanisms.
• Analysis of factors contributing to cardiac remodeling in CKD patients.
• Examination of animal models for insights into disease progression and therapeutic strategies.

Main Results:

• CKD involves numerous factors like altered hemodynamics, metabolic disturbances, uremic toxins, and inflammation that stress the heart.
• These factors lead to left-ventricular hypertrophy, fibrosis, capillary rarefaction, and heart failure.
• Fibrosis in the heart contributes to electrical instability and sudden cardiac death.

Conclusions:

• Cardiorenal crosstalk is a critical driver of cardiac disease in CKD.
• Understanding these mechanisms is essential for developing novel therapeutics.
• Further research using animal models may elucidate new treatment strategies for uremia-induced cardiac pathology.